Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

glioblastoma; glioma; temozolomide; radiotherapy; immunotherapy; novel therapy; personalized treatment; drug repurposing; invasion; invadopodia; ion channels; gene therapy; viral vectors; brain tumor; nanomedicine; cancer stem cell; targeted therapy; brain cancer; cell cycle; differentiation; proliferation; RAS; SRGAP2; stem cell; TP53; glioblastoma multiforme; GBM; nerve/glial antigen 2; NG2; CK2; CX-4945; migration; CRISPR/Cas9; anticancer; anti-angiogenesis; thyrointegrin αvβ3; PEG; triazole tetrac; P-bi-TAT; P-m-TAT; tetrac; one-carbon metabolism; de novo purine synthesis; metabolic reprogramming; metabolic treatment; vaccine; immune checkpoint inhibitors; chimeric antigen receptor (CAR) T cells; glioblastoma (GB); prolyl-oligopeptidase (POP); vascular endothelial growth factor (VEGF); transforming growth factor-β (TGF-β); angiopoietin (Ang); endothelial nitric oxide synthase (eNOS); newly diagnosed glioblastoma; recurrent glioblastoma; new trial design; drug-inducible gene expression; Mardepodect; Regorafenib; drug targets; tumor antigens; renin–angiotensin system; pluripotent stem cells; organoids; cancer stem cells; cancer stem cell niche; tumor microenvironment; n/a